{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T06:28:25Z","timestamp":1719469705818},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12272-001-1229-y","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T15:00:06Z","timestamp":1213801206000},"page":"798-804","source":"Crossref","is-referenced-by-count":2,"title":["Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets"],"prefix":"10.1007","volume":"31","author":[{"given":"Yun-Seok","family":"Rhee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Young","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tack-Oon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Woong","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,19]]},"reference":[{"key":"1229_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"G. L. Amidon","year":"1995","unstructured":"Amidon, G. L., Lennernas, H., Shah, V. P., and Crison, J. R., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12, 413\u2013420 (1995).","journal-title":"Pharm. Res."},{"key":"1229_CR2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clinthera.2005.06.015","volume":"27","author":"L. A. Boothby","year":"2005","unstructured":"Boothby, L. A. and Doering, P. L., Acamprosate for the treatment of alcohol dependence. Clin. Ther., 27, 695\u2013714 (2005).","journal-title":"Clin. Ther."},{"key":"1229_CR3","first-page":"311","volume":"10","author":"C. Chabenat","year":"1988","unstructured":"Chabenat, C., Chretien, P., Daoust, M., Moore, N., Andre, D., Lhuintre, J. P., Saligaut, C., Boucly, P., and Boismare, F., Physicochemical, pharmacological and pharmacokinetic study of a new GABAergic compound, calcium acetylhomotaurinate. Methods Find. Exp. Clin. Pharmacol., 10, 311\u2013317 (1988).","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"1229_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.nucmedbio.2003.11.001","volume":"31","author":"J. Courtyn","year":"2004","unstructured":"Courtyn, J., Cornelissen, B., Oltenfreiter, R., Vandecapelle, M., Slegers, G., and Strijckmans, K., Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography. Nucl. Med. Biol., 31, 649\u2013654 (2004).","journal-title":"Nucl. Med. Biol."},{"key":"1229_CR5","volume-title":"Pharmacokinetics","year":"1982","unstructured":"Gibaldi, M. and Perrier, D. (eds), Pharmacokinetics (2nd edn). Marcel Dekker, New York (1982).","edition":"2nd edn"},{"key":"1229_CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-3659(98)00106-0","volume":"57","author":"T. Ishibashi","year":"1999","unstructured":"Ishibashi, T., Hatano, H., Kobayashi, M., Mizobe, M., and Yoshino, H., In vivo drug release behavior in dogs from a new colon-targeted delivery system. J. Control. Release, 57, 45\u201353 (1999a).","journal-title":"J. Control. Release"},{"key":"1229_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-3659(99)00005-X","volume":"59","author":"T. Ishibashi","year":"1999","unstructured":"Ishibashi, T., Ikegami, K., Kubo, H., Kobayashi, M., Mizobe, M., and Yoshino, H., Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC). J. Control. Release, 59, 361\u2013376 (1999b).","journal-title":"J. Control. Release"},{"key":"1229_CR8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1248\/bpb1978.11.563","volume":"11","author":"N. Kaniwa","year":"1988","unstructured":"Kaniwa, N., Aoyagi, N., Ogata, H., and Ejima, A., Gastric emptying rate of drug preparations. I. Effect of size of dosage forms, foods and species on gastric emptying rate. J. Pharmacobio-Dyn., 11, 563\u2013570 (1988).","journal-title":"J. Pharmacobio-Dyn."},{"key":"1229_CR9","unstructured":"Lipha Pharmaceuticals, Inc., Briefing Document for Acamprosate 333 mg Tablets. Food and Drug Administration: Washington, DC, US. 1-311 (2002)."},{"key":"1229_CR10","first-page":"203","volume-title":"Recent Developments in Alcoholism","author":"B. J. Mason","year":"2003","unstructured":"Mason, B. J., Acamprosate. In: Galanter, M. (Ed.), Recent Developments in Alcoholism, Springer, US., pp. 203\u2013215 (2003)."},{"key":"1229_CR11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/alcalc\/35.4.324","volume":"35","author":"P. M\u00e1s-Serrano","year":"2000","unstructured":"M\u00e1s-Serrano, P., Granero, L., Mart\u00edn-Algarra, R. V., Guerri, C., and Polache, A., Kinetic study of acamprosate absorption in rat small intestine. Alcohol Alcohol., 35, 324\u2013330 (2000).","journal-title":"Alcohol Alcohol."},{"key":"1229_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cnr.2005.08.011","volume":"5","author":"H. M. Pettinati","year":"2005","unstructured":"Pettinati, H. M. and Rabinowitz, A. R., Recent advances in the treatment of alcoholism. Clin. Neurosci. Res., 5, 151\u2013159 (2005).","journal-title":"Clin. Neurosci. Res."},{"key":"1229_CR13","doi-asserted-by":"crossref","unstructured":"Rhee, Y. S., Park, J. H., Park, S., Park, C. W., Lee, D. S., and Park, E. S., Quantitative determination of acamprosate calcium in beagle dog plasma by liquid chromatography\/mass\/mass spectrometry and its application to pharmacokinetic study. J. Pharm. Biomed. Anal., submitted for publication (2008).","DOI":"10.1007\/s12272-001-1265-7"},{"key":"1229_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00003088-199835050-00001","volume":"35","author":"S. Saivin","year":"1998","unstructured":"Saivin, S., Hulot, T., Chabac, S., Potgieter, A., Durbin, P., and Houin, G., Clinical pharmacokinetics of acamprosate. Clin. Pharmacokinet., 35, 331\u2013345 (1998).","journal-title":"Clin. Pharmacokinet."},{"key":"1229_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00023210-200519050-00006","volume":"19","author":"L. J. Scott","year":"2005","unstructured":"Scott, L. J., Figgitt, D. P., Keam, S. J., and Waugh, J., Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence. CNS Drugs, 19, 445\u2013464 (2005).","journal-title":"CNS Drugs"},{"key":"1229_CR16","unstructured":"U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Dissolution methods for drug product: Acamprosate calcium. (2005) http:\/\/www.accessdata.fda.gov\/scripts\/cder\/dissolution\/dsp_SearchResults_Dissolutions.cfm?PrintAll=1 . Accessed October 5, 2007."},{"key":"1229_CR17","unstructured":"U.S. Pharmacopeia (USP) 29, US Pharmacopeial Convention, Rockville, MD, Monograph 701: Disintegration (2006)."},{"key":"1229_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.drugpo.2006.03.005","volume":"17","author":"K. Witkiewitz","year":"2006","unstructured":"Witkiewitz, K. and Marlatt, G.A., Overview of harm reduction treatments for alcohol problems. Int. J. Drug Policy, 17, 285\u2013294 (2006).","journal-title":"Int. J. Drug Policy"},{"key":"1229_CR19","unstructured":"World Health Organization (WHO), Global status report on alcohol 2004. Geneva, Switzerland (2004)."},{"key":"1229_CR20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/A:1016473601633","volume":"19","author":"L. X. Yu","year":"2002","unstructured":"Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M. L., Lee, V. H., and Hussain, A. S., Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res., 19, 921\u2013925 (2002).","journal-title":"Pharm. Res."},{"key":"1229_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bdd.322","volume":"23","author":"T. Zornoza","year":"2002","unstructured":"Zornoza, T., Guerri, C., Polache, A., and Granero, L., Disposition of acamprosate in the rat: influence of probenecid. Biopharm. Drug Dispos., 23, 283\u2013291 (2002).","journal-title":"Biopharm. Drug Dispos."},{"key":"1229_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejps.2004.04.004","volume":"22","author":"T. Zornoza","year":"2004","unstructured":"Zornoza, T., Cano-Cebri\u00e1n, M. J., Nalda-Molina, R., Guerri, C., Granero, L., and Polache, A., Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. Eur. J. Pharm. Sci., 22, 347\u2013356 (2004).","journal-title":"Eur. J. Pharm. Sci."},{"key":"1229_CR23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/bdd.513","volume":"27","author":"T. Zornoza","year":"2006","unstructured":"Zornoza, T., Cano-Cebri\u00e1n, M.J., Hip\u00f3lito, L., Granero, L., and Polache, A., Evidence of a flip-flop phenomenon in acamprosate pharmacokinetics: an in vivo study in rats. Biopharm. Drug Dispos., 27, 305\u2013311 (2006).","journal-title":"Biopharm. Drug Dispos."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-001-1229-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-001-1229-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-001-1229-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:00:27Z","timestamp":1684443627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-001-1229-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1007\/s12272-001-1229-y","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}